Metraipolis › archive › dc_df335477dceb
ABT-510 — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/ABT-510
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T23:30:38.923Z
- SHA-256 of the archived text
38e88bae14ed1889ebb0ac7b14cc3df4e8beec9aa01de8c1d0ca40278fc64523- Stable URL of this page
https://metraipolis.com/documento/dc_df335477dceb
How to cite
ABT-510 — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/ABT-510 (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_df335477dceb (Metraipolis archive dc_df335477dceb, sha256 38e88bae14ed1889ebb0ac7b14cc3df4e8beec9aa01de8c1d0ca40278fc64523)
BibTeX
@misc{dcdf335477dceb,
title = {ABT-510 — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/ABT-510},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_df335477dceb; sha256 38e88bae14ed1889ebb0ac7b14cc3df4e8beec9aa01de8c1d0ca40278fc64523},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/ABT-510. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
ABT-510 is a molecular therapeutic drug that was the subject of research as a potential treatment for cancer. According to the Journal of Clinical Oncology, ABT-510 is a "subcutaneously (SC) administered nonapeptide thrombospondin analogue." Following inconclusive phase I clinical trials, a 2007 phase II study of ABT-510 for treatment of metastatic melanoma failed to reach its primary endpoint resulting in termination of the study. Only three out of twenty-one patients reached the primary endpoint of progression-free survival at 18 weeks, but these three patients remained progression-free for 21, 34, and 42 weeks. However, biomarker data collected during this study showed a decrease in VEGF-C, circulating endothelial cells, and CD146 and CD34/133 counts, and a maximum tolerated dose has still not been established. Further study could consider a higher dose and/or combination treatment. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «ABT-510» — https://en.wikipedia.org/wiki/ABT-510 Wikidata Q27095674: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q27095674 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/ABT-510?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1330647817, consultata il 2026-11-06T23:26:19.494Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 0c38be9c78bac38bb1cba521fa19714589c81bde858bca2f2f2b321cd13f9db4